What Is the Role of the Blood-Brain Barrier in Drug Design?
•
5 min read
Nearly 98% of small-molecule drugs and virtually all large-molecule drugs fail to cross the blood-brain barrier (BBB), presenting a formidable challenge for neurotherapeutics. Understanding the complex and multifaceted role of the blood-brain barrier in drug design is therefore critical for developing effective treatments for a wide range of neurological disorders.
